No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Anebulo Pharmaceuticals | 10-Q: Quarterly report
Express News | Anebulo Pharmaceuticals, Inc. Q3 Basic EPS USD -0.06
Express News | Anebulo Pharmaceuticals, Inc. Q3 Net Income USD -1.7 Million
Express News | Anebulo Pharmaceuticals, Inc. Q3 Operating Expenses USD 1.7 Million
Express News | Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully
No Data